Alexa, What is Eliquis and Xarelto?

Cedars-Sinai Medical Center

Status: Terminated

Conditions: Patient Satisfaction; Patient Engagement

Treatments: Other: Amazon Alexa based voice recording patient education

Study type: Interventional

Funder types: Other

Identifiers

NCT04790773

STUDY00001194

Details and patient eligibility

About

The purpose of this study is to evaluate the effectiveness of providing patient medication education about Eliquis and Xarelto through an Amazon Alexa based voice recording.

Full description

Anticoagulants are considered high-risk medications due to the risk of major bleeding. The Federal Drug and Food Administration (FDA) MedWatch reporting system found that anticoagulants had the most adverse drug event (ADE) reports in 2011. Anticoagulants have also been reported as one of the leading drug classes contributing to emergency department visits3. Given the potential for serious adverse events, providing effective education to increase patient knowledge and awareness of those risks are essential. Incorporating technology into health care is becoming increasingly popular and has been shown to be effective for patient education. One reason is that technology can consistently provide complete patient education and is not subject to educator variability in providing this education.

Enrollment: 36 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria (Patients):

• 18 years of age or older
• Have been prescribed either apixaban or rivaroxaban during their inpatient stay
• Consent to participating in the study

Inclusion Criteria (Nurses):

• Providing direct patient care in select general medicine and orthopedic surgical units
• Consent to participating in the study

Exclusion Criteria:

• Patients will be excluded if they have documented altered mental status, do not speak English, or are being prescribed rivaroxaban or apixaban on discharge only.
• Nurses will be excluded if not providing direct patient care in select general medicine and orthopedic surgical units
• Nurses declining participation

Trial design

Primary purpose: Health Services Research

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

36 participants in 2 patient groups

Standard of care

No Intervention group

Description:

Patient's will receive standard education on Xarelto and Eliquis per usual process without use of Alexa based voice recording.

Alexa Education

Active Comparator group

Description:

Patient's will opt in to receive initial education via Alexa based voice recording on Xarelto and Eliquis.

Treatment:

Other: Amazon Alexa based voice recording patient education